Quanterix upgraded by Goldman with a new price target
$QTRX
Biotechnology: Laboratory Analytical Instruments
Industrials
Goldman upgraded Quanterix from Neutral to Buy and set a new price target of $27.00 from $13.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/11/2025 | $5.00 | Buy → Hold | Canaccord Genuity |
| 2/1/2024 | $30.00 | Sector Outperform | Scotiabank |
| 9/25/2023 | $25.00 → $32.00 | Hold → Buy | Canaccord Genuity |
| 8/8/2023 | $30.00 | Market Perform → Outperform | SVB Securities |
| 5/23/2023 | $13.00 → $27.00 | Neutral → Buy | Goldman |
| 8/15/2022 | $40.00 → $12.00 | Buy → Hold | Canaccord Genuity |
| 8/9/2022 | $38.00 → $18.00 | Outperform → Market Perform | Cowen |
| 8/9/2022 | $35.00 → $15.00 | Outperform → Mkt Perform | SVB Leerink |